Literature DB >> 27566387

Successful treatment with weekly high-dose erlotinib against meningeal metastases from epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma.

Ryota Kanemaru1, Yoshiteru Morio2, Hidenori Takekawa3, Hitomi Jo4, Fumiko Kasuga5, Ryo Koyama6, Satomi Shiota7, Tetsutaro Nagaoka8, Kazuhisa Takahashi9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27566387     DOI： 10.1016/j.resinv.2016.04.001

Source DB:  PubMed          Journal:  Respir Investig        ISSN： 2212-5345


× No keyword cloud information.
  2 in total

1.  Targeted therapy for leptomeningeal metastases in non-small cell lung cancer - Changing treatment paradigms.

Authors:  Binay Kumar Shah; Isaac Pak; Nibash Budhathoki; Kayla Buker
Journal:  Chin J Cancer Res       Date:  2017-12       Impact factor: 5.087

2.  Cerebrospinal fluid diversion and outcomes for lung cancer patients with leptomeningeal carcinomatosis.

Authors:  Yan-Hua Su; Chi-Lu Chiang; Huai-Che Yang; Yong-Sin Hu; Yu-Wei Chen; Yung-Hung Luo; Ching-Jen Chen; Hsiu-Mei Wu; Chung-Jung Lin; Cheng-Chia Lee
Journal:  Acta Neurochir (Wien)       Date:  2021-03-01       Impact factor: 2.216
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.